GNAS and gastric cancer: In addition, the GC cases with higher GNAS mRNA expression levels showed significantly worse survival (HR, 2.09, 95% CI, 1.22-3.57, p=0.007) compared to lower expression subjects after adjusting for age, gender, pathological stage, H.pylori infection, targeted molecular therapy and radiation therapy (Figure 1B).